Keywords: Bleeding; Atrial fibrillation; Risk factors; HAS-BLED;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Atrial fibrillation; Bleeding; HAS-BLED; Risk factors; Risk stratification;
Keywords: Atrial fibrillation; Anticoagulants; CHADS2; HAS-BLED; Prevalence; Population-based study;
Keywords: AF; atrial fibrillation; CHA2DS2-VASc; congestive heart failure, hypertension, age â¥75, diabetes, stroke or transient ischemic attack, vascular disease, age between 65 and 74 and female sex; HAS-BLED; hypertension, abnormal renal and/or liver function,
Keywords: ACT; activated clotting time; AF; atrial fibrillation; CHA2DS2-VASc; score for prediction of estimated risk of stroke in patients with non-valvular atrial fibrillation; EP; electrophysiologic; HAS-BLED; score that estimates risk of major bleeding for pati
Keywords: Fibrilación auricular; Estratificación del riesgo; Ictus isquémico; Hemorragia intracraneal; Función renal; Biomarcadores; CHA2DS2-VASc; HAS-BLED; Beneficio clÃnico neto; Atrial fibrillation; Risk stratification; Ischemic stroke; Intracranial bleedin
Keywords: AF; atrial fibrillation; APT; antiplatelet therapy; BARC; Bleeding Academic Research Consortium; CHA2DS2-VASc; congestive heart failure, hypertension, age ⥠75 years (doubled), diabetes, stroke (doubled), vascular disease, age 65 to 74 years, sex catego
Keywords: AF; atrial fibrillation; CHADS2; congestive heart failure, hypertension, age ⥠75 years, diabetes, stroke (doubled); CHA2DS2-VASc; congestive heart failure, hypertension, age ⥠75 years (doubled), diabetes, stroke or transient ischemic attack (doubled
Keywords: AF; atrial fibrillation; ATRIA; Anticoagulation and Risk Factors in Atrial Fibrillation; CHADS2; congestive heart failure, hypertension, age ⥠75 years, diabetes, prior stroke or transient ischemic attack; CHA2DS2-VASc; congestive heart failure, hyperte
The risk of acute kidney injury in Asians treated with apixaban, rivaroxaban, dabigatran, or warfarin for non-valvular atrial fibrillation: A nationwide cohort study in Taiwan
Keywords: AF; atrial fibrillation; AKI; acute kidney injury; CHA2DS2-VASc; congestive heart failure, hypertension, aged 75â¯years or older, diabetes mellitus, previous stroke/transient ischemic attack, vascular disease, aged 65 to 74â¯years, female; CKD; chronic
A Propensity Score Matched Comparison of Clinical Outcomes in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Comparing the “Real-World” vs Clinical Trials
Keywords: AF; atrial fibrillation; AMADEUS; Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation; CHA2DS2-VASc; Congestive heart failure or left ventricular dysfunction (1), Hypertension (1), Ageâ¥75 (2) or 65-74
Dual (Anticoagulant Plus Single Antiplatelet) vs Triple (Anticoagulant Plus Dual Antiplatelet) Antithrombotic Therapy - “Real World” Experience
Keywords: ACS; acute coronary syndrome; AF; atrial fibrillation; BARC; bleeding academic research consortium; CAD; coronary artery disease; CHA2DS2-VASc; congestive heart failure, hypertension, ageâ¯â¥â¯75p years (doubled), diabetes mellitus, prior stroke or TIA
Predictive performance of HAS-BLED risk score for long-term survival in patients with non-ST elevated myocardial infarction without atrial fibrillation
Keywords: HAS-BLED; CRUSADE; GRACE; TIMI; Survival; NSTEMI;
Non-Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction
Keywords: bleeding; dose; embolism; kidney disease; stroke; AF; atrial fibrillation; CI; confidence interval; CKD-EPI; Chronic Kidney Disease Epidemiology Collaboration; CrCl; creatinine clearance; eGFR; estimated glomerular filtration rate; FDA; U.S. Food and Drug
Predicting the Outcomes of Acute Ischemic Stroke with Rheumatic Heart Disease: The Values of CHADS2, CHA2DS2-VASc, and HAS-BLED Scores
Keywords: Stroke; rheumatic heart disease; CHADS2; CHA2DS2-VASc; HAS-BLED; outcomes;
Platelet reactivity in MitraClip patients
Keywords: CAD; coronary artery disease; HTPR; high on-treatment platelet reactivity; HAS-BLED; hypertension, abnormal renal/liver function, stroke, bleeding history or predisposition, labile international normalized ratio, elderly, drugs/alcohol concomitantly; LTA;
Initial experience with the WATCHMAN⢠left atrial appendage system for stroke prevention in atrial fibrillation: A single-centre registry
Keywords: Left atrial appendage closure; WATCHMANâ¢; Fibrillation auriculaire; Occlusion de l'auricule gauche; Prévention de l'accident vasculaire cérébral ischémique; Prothèse de WATCHMANâ¢; AF; atrial fibrillation; CHADS2; Cardiac failure, Hypertension
The HAS-BLED score predicts long-term major bleeding and death in anticoagulated non-valvular atrial fibrillation patients undergoing electrical cardioversion
Keywords: Atrial fibrillation; Electrical cardioversion; Haemorrhage; Mortality; Risk factors; HAS-BLED;
Stroke prevention using dabigatran in elderly Chinese patients with atrial fibrillation
Keywords: AF; atrial fibrillation; CHA2DS2-VASc; congestive heart failure (1 point), hypertension (1 point), age 65-74 years (1 point) and age â¥75 years (2 points), diabetes mellitus (1 point), prior stroke or transient ischemic attack (2 points), vascular dise
Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking Warfarin
Keywords: Anticoagulation; ATRIA; Bleeding; HAS-BLED; ORBIT; Risk assessment;
HAS-BLED score predicts risk of in-hospital major bleeding in patients with acute non-ST segment elevation myocardial infarction
Keywords: HAS-BLED; CRUSADE; ACUITY-HORIZONS; Major bleeding; NSTEMI;
Patients with atrial fibrillation and CHA2DS2-VASc score 1: “To anticoagulate or not to anticoagulate? That is the question!”
Keywords: ACC; American College of Cardiology; ACTIVE-W; Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events; AF; atrial fibrillation; AHA; American Heart Association; ARISTOTLE; Apixaban for Reduction in Stroke and Other Thrombo
Predictive accuracy of CHA2DS2-VASc and HAS-BLED scores in patients without atrial fibrillation undergoing percutaneous coronary intervention and discharged on dual antiplatelet therapy
Keywords: CHA2DS2-VASc; HAS-BLED; PCI; Stents;
Prevalence of Undiagnosed Atrial Fibrillation and of That Not Being Treated With Anticoagulant Drugs: the AFABE Study
Keywords: Atrial fibrillation; Prevalence; Population-based study; CHA2DS2-VASc; HAS-BLED; Anticoagulation for atrial fibrillationFibrilación auricular; Prevalencia; Estudio de base poblacional; CHA2DS2-VASc; HAS-BLED; Tratamiento anticoagulanteAF, atrial fibrillat
Prevalencia de la fibrilación auricular desconocida y la no tratada con anticoagulantes. Estudio AFABE
Keywords: Fibrilación auricular; Prevalencia; Estudio de base poblacional; CHA2DS2-VASc; HAS-BLED; Tratamiento anticoagulanteAtrial fibrillation; Prevalence; Population-based study; CHA2DS2-VASc; HAS-BLED; Anticoagulation for atrial fibrillationCHA2DS2-VASc, insufi
Development of a Novel Composite Stroke and Bleeding Risk Score in Patients With Atrial Fibrillation
Keywords: AF; atrial fibrillation; AMADEUS; Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation; AUC; area under the curve; CHADS2; congestive heart failure, hypertension, age ⥠75 years, diabetes, prior stroke
Antithrombotic Therapy in Atrial Fibrillation
Keywords: CHADS2; CHA2DS2-VASc; HAS-BLED; Dabigatran; Rivaroxaban; Apixaban;
Performance of the HEMORR2HAGES, ATRIA, and HAS-BLED Bleeding Risk–Prediction Scores in Patients With Atrial Fibrillation Undergoing Anticoagulation : The AMADEUS (Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial
Keywords: AMADEUS trial; ATRIA; atrial fibrillation; bleeding; HAS-BLED; HEMORR2HAGESAF, atrial fibrillation; ATRIA, Anticoagulation and Risk Factors in Atrial Fibrillation; DCA, decision-curve analysis; HAS-BLED, Hypertension, Abnormal Renal/Liver Function, Stroke